Summary
BPC-157 is favored at 79% as of 28 Jul 2026, 18:33 UTC across 7 markets. Kalshi odds.
- BPC-157: 79% (24h change 0%)
- KPV: 79% (24h change 0%)
- MOTS-c: 70% (24h change 0%)
- Semax: 36% (24h change 0%)
- Epitalon: 35% (24h change 0%)
- Emideltide: 16% (24h change 0%)
- TB-500: 12% (24h change 0%)
policy7 marketsLIVE
Which peptides will the FDA propose adding to the 503A Bulks List?
Trade ↗Odds history
Loading chart